Daclizumab Subcutaneous and Griseofulvin Ultramicrosize Tablets
Determining the interaction of Daclizumab Subcutaneous and Griseofulvin Ultramicrosize Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: griseofulvin
Brand name: Grifulvin V, Fulvicin P/G, Fulvicin U/F, Gris-PEG, Grisactin Ultra, Grisactin 250, Grisactin 500, Griseofulicin, Griseofulvic
Synonyms: Griseofulvin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Guaiatussin AC
- Daclizumab Subcutaneous-Guaifen DAC
- Daclizumab Subcutaneous-Guaifenesin AC Liquid
- Daclizumab Subcutaneous-Guaifenesin and Codeine
- Daclizumab Subcutaneous-Guaifenesin and Dextromethorphan Capsules and Tablets
- Daclizumab Subcutaneous-Guaifenesin and Dextromethorphan Extended-Release Tablets
- Griseofulvin Ultramicrosize Tablets-Dacogen
- Griseofulvin Ultramicrosize Tablets-Dacomitinib
- Griseofulvin Ultramicrosize Tablets-Dactinomycin
- Griseofulvin Ultramicrosize Tablets-Dactinomycin Injection
- Griseofulvin Ultramicrosize Tablets-Dactinomycin Intravenous
- Griseofulvin Ultramicrosize Tablets-Daklinza